TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort. Demichelis F, Fall K, Perner S, Andrén O, Schmidt F, Setlur SR, Hoshida Y, Mosquera JM, Pawitan Y, Lee C, Adami HO, Mucci LA, Kantoff PW, Andersson SO, Chinnaiyan AM, Johansson JE, Rubin MA, Department of Pathology, Brigham and Women's Hospital, Boston, MA; Harvard Medical School, Boston, MA and...

Urologic Oncology: Seminars and Original Investigations

Volumn 25, Issue 5, 2007, Pages 448-449

  Kibel, Adam S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GROWTH; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; ERG GENE; GENE EXPRESSION REGULATION; GENE FUSION; GENE IDENTIFICATION; GENETIC ASSOCIATION; HUMAN; LETHALITY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHORT SURVEY; TMPRSS2 GENE; WATCHFUL WAITING;

EID: 34548522905     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2007.07.004     Document Type: Short Survey

References (1)

1. Tomlins S.A., Rhodes D.R., Perner S., et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310 (2005) 644-648